Compatibility of argatroban with selected cardiovascular agents.
Honisko
Marcia E
ME
College of Pharmacy, The University of Toledo, Toledo, OH 43606, USA.
Fink
Jodie M
JM
Militello
Michael A
MA
Mauro
Vincent F
VF
Alexander
Kenneth S
KS
D000638:Amiodarone / Q000737:chemistry; D000925:Anticoagulants / Q000737:chemistry*; D001120:Arginine / Q000031:analogs & derivatives; D002317:Cardiovascular Agents / Q000737:chemistry*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D018818:Fenoldopam / Q000737:chemistry; D005665:Furosemide / Q000737:chemistry; D006801:Humans; D007263:Infusions, Parenteral; D008012:Lidocaine / Q000737:chemistry; D020105:Milrinone / Q000737:chemistry; D020097:Natriuretic Peptide, Brain / Q000737:chemistry; D005996:Nitroglycerin / Q000737:chemistry; D009599:Nitroprusside / Q000737:chemistry; D010875:Pipecolic Acids / Q000737:chemistry*; D013449:Sulfonamides; D014667:Vasopressins / Q000737:chemistry
D000925:Anticoagulants; D002317:Cardiovascular Agents; D010875:Pipecolic Acids; D013449:Sulfonamides; D014667:Vasopressins; D020097:Natriuretic Peptide, Brain; D009599:Nitroprusside; D005665:Furosemide; D001120:Arginine; D008012:Lidocaine; D005996:Nitroglycerin; D018818:Fenoldopam; C031942:argatroban; D020105:Milrinone; D000638:Amiodarone